FBRX Valuation

Forte Biosciences Inc (FBRX) has a current Price-to-Book (P/B) ratio of 4.53. Compared to its 3-year average P/B ratio of 1.15 , the current P/B ratio is approximately 293.81% higher. Relative to its 5-year average P/B ratio of 2.14, the current P/B ratio is about 111.79% higher. Forte Biosciences Inc (FBRX) has a Forward Free Cash Flow (FCF) yield of approximately -11.70%. Compared to its 3-year average FCF yield of -99.51%, the current FCF yield is approximately -88.25% lower. Relative to its 5-year average FCF yield of -74.95% , the current FCF yield is about -84.39% lower.